Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
The impact of patient characteristics on lifetime risk of revision following knee and hip replacement: evidence from linked primary care and hospital records
Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
Do silicone breast implants cause connective tissue disease? There is still no clear evidence that they do
Epigenetic gene promoter methylation at birth is associated with child's later adiposity.
Birthweight, vitamin D receptor gene polymorphism, and risk of lumbar spine osteoarthritis.
Osteoporosis. Coming to the crunch.
BIRTH WEIGHT IS RELATED TO HAND OSTEOARTHRITIS IN MIDDLE-AGED MEN
Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK
Standardising biochemical assessment of bone turnover in osteoporosis.
Myocardial infarction in rheumatoid arthritis: The effects of DMARDs and prednisolone
Pain tolerance in upper limb disorders: findings from a community survey.
The impact of the enhanced recovery pathway and other factors on outcomes and costs following hip and knee replacement: routine data study
Effects of hypothyroidism on the structure and mechanical properties of bone in the ovine fetus.
Reamed intramedullary nailing versus circular frame external fixation for segmental tibial fractures (STIFF-F): a mixed methods feasibility study
STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRTTIS PROGRESSION
Excess mortality in osteoarthritis.
Peri-implantation and late gestation maternal undernutrition differentially alter pathways of insulin and IGF-1 action in fetal sheep skeletal muscle
Effectiveness of nail bed repair in children with or without replacing the fingernail: the NINJA multicentre randomised controlled trial
Comparative risk of venous thromboembolism among users of different anti-osteoporosis drugs in the UK National Health Service and in Catalonia, Spain: A propensity-matched cohort study